TWD 13.6
(8.37%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 79.84 Million TWD | -8.4% |
2022 | 87.17 Million TWD | 6.89% |
2021 | 81.55 Million TWD | -24.11% |
2020 | 107.47 Million TWD | -17.46% |
2019 | 130.2 Million TWD | 5.4% |
2018 | 123.53 Million TWD | 7.69% |
2017 | 114.7 Million TWD | 4.65% |
2016 | 109.6 Million TWD | 153.75% |
2015 | 43.19 Million TWD | -57.13% |
2014 | 100.75 Million TWD | 19.11% |
2013 | 84.58 Million TWD | -15.73% |
2012 | 100.37 Million TWD | 14.65% |
2011 | 87.55 Million TWD | 3.4% |
2010 | 84.67 Million TWD | -17.49% |
2009 | 102.62 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 64.64 Million TWD | -19.05% |
2024 Q2 | 68.9 Million TWD | 6.6% |
2023 Q3 | 77.76 Million TWD | -0.59% |
2023 Q4 | 79.84 Million TWD | 2.69% |
2023 FY | 79.84 Million TWD | -8.4% |
2023 Q1 | 74.59 Million TWD | -14.43% |
2023 Q2 | 78.22 Million TWD | 4.87% |
2022 Q3 | 64.26 Million TWD | -2.12% |
2022 Q2 | 65.65 Million TWD | 9.57% |
2022 FY | 87.17 Million TWD | 6.89% |
2022 Q1 | 59.92 Million TWD | -26.53% |
2022 Q4 | 87.17 Million TWD | 35.65% |
2021 Q1 | 115.36 Million TWD | 7.34% |
2021 Q2 | 106.96 Million TWD | -7.28% |
2021 FY | 81.55 Million TWD | -24.11% |
2021 Q3 | 91.84 Million TWD | -14.13% |
2021 Q4 | 81.55 Million TWD | -11.2% |
2020 FY | 107.47 Million TWD | -17.46% |
2020 Q3 | 124.15 Million TWD | 3.8% |
2020 Q1 | 115.43 Million TWD | -11.34% |
2020 Q2 | 119.6 Million TWD | 3.61% |
2020 Q4 | 107.47 Million TWD | -13.43% |
2019 Q1 | 114.01 Million TWD | -7.7% |
2019 Q3 | 123 Million TWD | 25.92% |
2019 Q4 | 130.2 Million TWD | 5.86% |
2019 FY | 130.2 Million TWD | 5.4% |
2019 Q2 | 97.67 Million TWD | -14.33% |
2018 Q2 | 96.4 Million TWD | 1.07% |
2018 Q3 | 117.19 Million TWD | 21.56% |
2018 Q4 | 123.53 Million TWD | 5.41% |
2018 Q1 | 95.38 Million TWD | -16.85% |
2018 FY | 123.53 Million TWD | 7.69% |
2017 Q1 | 92.53 Million TWD | -15.58% |
2017 FY | 114.7 Million TWD | 4.65% |
2017 Q4 | 114.7 Million TWD | 8.18% |
2017 Q3 | 106.03 Million TWD | 5.18% |
2017 Q2 | 100.81 Million TWD | 8.95% |
2016 Q2 | 112.24 Million TWD | 316.95% |
2016 Q1 | 26.92 Million TWD | -37.68% |
2016 FY | 109.6 Million TWD | 153.75% |
2016 Q3 | 105.1 Million TWD | -6.36% |
2016 Q4 | 109.6 Million TWD | 4.28% |
2015 Q2 | 41.09 Million TWD | -35.06% |
2015 FY | 43.19 Million TWD | -57.13% |
2015 Q4 | 43.19 Million TWD | 12.78% |
2015 Q3 | 38.3 Million TWD | -6.81% |
2015 Q1 | 63.28 Million TWD | -37.18% |
2014 Q2 | 96.68 Million TWD | -10.79% |
2014 Q1 | 108.38 Million TWD | 28.14% |
2014 Q3 | 94.48 Million TWD | -2.28% |
2014 Q4 | 100.75 Million TWD | 6.63% |
2014 FY | 100.75 Million TWD | 19.11% |
2013 Q1 | 64.32 Million TWD | -35.91% |
2013 Q3 | 64.67 Million TWD | -8.81% |
2013 Q2 | 70.91 Million TWD | 10.24% |
2013 FY | 84.58 Million TWD | -15.73% |
2013 Q4 | 84.58 Million TWD | 30.79% |
2012 Q2 | 55.18 Million TWD | -18.44% |
2012 FY | 100.37 Million TWD | 14.65% |
2012 Q1 | 67.65 Million TWD | -22.72% |
2012 Q4 | 100.37 Million TWD | 21.94% |
2012 Q3 | 82.31 Million TWD | 49.17% |
2011 Q2 | 61.11 Million TWD | -28.01% |
2011 Q1 | 84.89 Million TWD | 0.26% |
2011 Q3 | 66.49 Million TWD | 8.8% |
2011 Q4 | 87.55 Million TWD | 31.68% |
2011 FY | 87.55 Million TWD | 3.4% |
2010 FY | 84.67 Million TWD | -17.49% |
2010 Q4 | 84.67 Million TWD | 0.0% |
2009 FY | 102.62 Million TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Grape King Bio Ltd | 3.88 Billion TWD | 97.943% |
Standard Chem & Pharm CO., LTD. | 3.05 Billion TWD | 97.383% |
Maywufa Company Ltd. | 794.91 Million TWD | 89.955% |
ScinoPharm Taiwan, Ltd. | 1.35 Billion TWD | 94.116% |
Lotus Pharmaceutical Co., Ltd. | 15.65 Billion TWD | 99.49% |
LIWANLI Innovation Co., Ltd. | 50.66 Million TWD | -57.617% |
YungShin Global Holding Corporation | 3.59 Billion TWD | 97.78% |
SCI Pharmtech, Inc. | 1.59 Billion TWD | 94.981% |
Formosa Laboratories, Inc. | 5.42 Billion TWD | 98.528% |
PharmaEssentia Corporation | 3.32 Billion TWD | 97.596% |
Bora Pharmaceuticals Co., LTD. | 13.28 Billion TWD | 99.399% |